Delivery Order SPE2DB22D1103-SPE2DB25FH3E0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, for $6,797.70 to supply HUMIRA (CF) Pen 40 mg/0.4 mL units. This non-competitive delivery order was issued under a firm fixed price structure with a completion date of July 31, 2025, and represents a single transaction on the company's broader pharmaceutical supply contract with DLA. The place of performance is located at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,398.85 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $32,686.99 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on June 20, 2025, with an ultimate completion date of June 23, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $19,051.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. The award, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,587.22 to AmerisourceBergen Drug Corp for the supply of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $32,216.41 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used to treat various inflammatory conditions. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, was competitively awarded without set-aside restrictions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical product. This firm fixed price delivery order, valued at $6,794.50, was competitively awarded without set-aside provisions and is scheduled for completion by August 19, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,445.94 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 MG/0.4 MLS, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product for immune-mediated conditions. Awarded on August 10, 2025, with an ultimate completion date of August 11, 2025, this firm fixed price delivery order represents a competitive award with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,394.58 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used to treat inflammatory conditions. The contract was awarded on August 19, 2025, with a completion date of August 20, 2025, and employs firm fixed price pricing with no set-aside designation. The product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH3E0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,041.43 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical products. This is a firm fixed price, competitive delivery order with no set-aside designation, with an ultimate completion date of September 25, 2025. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract supports critical federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key vendor within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/24/25 |